Skip to main content
. 2022 Nov 7;207(6):740–756. doi: 10.1164/rccm.202203-0490OC

Table 3.

Comparison of the Relative Abundance of Bacterial Species Differentially Abundant in Patients with Pulmonary Arterial Hypertension Compared with Healthy Control Subjects on Linear Discriminant Analysis of Effect Size

      Model 1*
Model 2
Species Name PAH
Relative Abundance (SD)
Healthy
Relative Abundance (SD)
β Coefficient (95% CI) P Value β Coefficient (95% CI) P Value
Bacterial species enriched in patients with PAH vs. healthy control subjects            
B. vulgatus 10.8 (11.9) 2.9 (3.7) 7.8 (1.3 to 14.4) 0.019 9.8 (1.3 to 14.1) <0.001
P. distasonis 5.3 (6.9) 0.9 (1.1) 3.9 (0.3 to 7.5) 0.035 4.4 (1.7 to 7.2) 0.002
B. thetaiotaomicron 4.6 (8.1) 0.6 (0.4) 2.7 (−1.4 to 6.8) 0.199 3.3 (0.2 to 6.5) 0.037
E. coli 2.3 (6.1) 0.1 (0.5) 0.1 (−2.9 to 3.3) 0.923 1.3 (−1.1 to 3.7) 0.299
K. pneumoniae 0.7 (2.8) 0 (0) 1.3 (−0.6 to 3.1) 0.178 0.8 (−0.6 to 2.1) 0.274
R. gnavus 0.6 (1.4) 0.4 (1.7) −0.1 (−1.0 to 0.8) 0.806 −0.1 (−0.7 to 0.6) 0.848
P. goldsteinii 0.3 (1.3) 0 (0) 0.4 (−0.2 to 1.1) 0.203 0.03 (−0.5 to 0.5) 0.888
Bacterial species with reduced abundance in patients with PAH vs. healthy control subjects            
F. prausnitzii 1.8 (2.3) 7.3 (5.6) −3.8 (−6.6 to −1.5) 0.002 −4.9 (−6.7 to −3.1) <0.001
E. rectale 0.6 (1.2) 6.6 (8.7) −6.2 (−9.4 to −3.0) <0.001 −5.9 (−8.4 to −3.4) <0.001
R. bicirculans 0.1 (0.5) 3.4 (7.7) −3.1 (−5.8 to −0.4) 0.023 −3.2 (−5.2 to −1.1) 0.002
R. faecis 0.5 (1.4) 3.2 (4.9) −2.4 (−4.4 to −0.5) 0.015 −2.6 (−4.0 to −1.1) 0.001
Prevotella sp. CAG 873 0 (0) 1.7 (9.8) −4.8 (−8.0 to −1.6) 0.004 −1.7 (−4.3 to 0.8) 0.190
R. inulinivorans 0.3 (0.6) 0.7 (0.8) −0.4 (−0.9 to −0.1) 0.067 −0.4 (−0.7 to −0.1) 0.034
C. comes 0.1 (0.1) 0.6 (1.1) −0.5 (−0.9 to −0.1) 0.014 −0.6 (−0.9 to −0.3) <0.001
B. coprocola 0 (0) 0.3 (1.2) −0.3 (−0.7 to 0.2) 0.235 −0.3 (−0.6 to 0.0) 0.050
B. obeum 0.2 (0.2) 0.6 (0.9) −0.5 (−0.8 to −0.1) 0.005 −0.5 (−0.7 to −0.2) <0.001
Clostridium sp. CAG 167 0.1 (0.3) 0.4 (0.8) −0.2 (−0.5 to 0.1) 0.275 −0.3 (−0.6 to −0.1) 0.009
Firmicutes sp. CAG 110 0.0 (0.1) 0.3 (1.3) −0.4 (−0.9 to 0.1) 0.114 −0.3 (−0.7 to 0.1) 0.073
D. succinatiphilus 0 (0) 0.1 (0.5) −0.1 (−0.3 to 0.1) 0.379 −0.1 (−0.2 to 0.1) 0.177
D. formicigenerans 0.1 (0.1) 0.4 (0.4) −0.3 (−0.5 to −0.1) <0.001 −0.3 (−0.4 to −0.2) <0.001
Oscillibacter sp. 57 20 0.2 (0.6) 0.4 (0.5) −0.3 (−0.7 to 0.1) 0.136 −0.1 (−0.4 to 0.1) 0.316
R. lactaris 0.1 (0.3) 0.4 (0.9) −0.1 (−0.5 to 0.2) 0.412 −0.3 (−0.5 to 0.0) 0.060

Definition of abbreviations: B. coprocola = Bacteroides coprocola; B. obeum = Blautia obeum; B. thetaiotaomicron = Bacteroides thetaiotaomicron; B. vulgatus = Bacteroides vulgatus; CAG = coabundance gene; C. comes = Coprococcus comes; CI = confidence interval; D. formicigenerans = Dorea formicigenerans; D. succinatiphilus = Dialister succinatiphilus; E. coli = Escherichia coli; E. rectale = Eubacterium rectale; F. prausnitzii = Faecalibacterium prausnitzii; K. pneumoniae = Klebsiella pneumoniae; PAH = pulmonary arterial hypertension; P. distasonis = Parabacteroides distasonis; P. goldsteinii = Parabactereroides goldsteinii; R. bicirculans = Ruminococcus bicirculans; R. faeci = Roseburia faecis; R. gnavus = Ruminococcus gnavus; R. inulinivorans = Roseburia inulinivorans; R. lactaris = Ruminococcus lactaris.

*

Adjusted for age, sex, body mass index, smoking status, and recent antibiotic use.

Adjusted for the Charlson comorbidity index.